您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2014, Vol. 52 ›› Issue (7): 71-74.doi: 10.6040/j.issn.1671-7554.1.2014.003

• 临床医学 • 上一篇    下一篇

35岁以下女性乳腺癌患者的临床病理特征

孙莹1, 于晶2, 魏军民1, 樊聪1, 王秀问1, 高鹏3, 江立玉4, 马婷婷4   

  1. 1. 山东大学齐鲁医院肿瘤中心化疗科, 山东 济南 250012;
    2. 山东医学高等专科学校, 山东 济南 250002;
    3. 山东大学齐鲁医院病理科, 山东 济南 250012;
    4. 山东大学齐鲁医院乳腺外科, 山东 济南 250012
  • 收稿日期:2014-03-20 修回日期:2014-06-26 出版日期:2014-07-10 发布日期:2014-07-10
  • 通讯作者: 魏军民。E-mail：weijunmin2002@yahoo.com E-mail:weijunmin2002@yahoo.com

Clinical and pathological characteristics of breast carcinoma in women aged 35 years or younger

SUN Ying1, YU Jing2, WEI Junmin1, FAN Cong1, WANG Xiuwen1, GAO Peng3, JIANG Liyu4, MA Tingting4   

  1. 1. Department of Chemotherapy, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China;
    2. Shandong Medical College, Jinan 250002, Shandong, China;
    3. Department of Pathology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China;
    4. Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Received:2014-03-20 Revised:2014-06-26 Online:2014-07-10 Published:2014-07-10

PDF (PC)

121

摘要： 目的 分析35岁以下女性乳腺癌患者的临床病理特征。方法 回顾分析山东大学齐鲁医院2007年1月1日至2012年12月31日收治的153例35岁以下乳腺癌的发病特点及各分子型的临床病理特征。结果 该组患者首发症状以乳房肿块为主，107例（69.9%）在出现症状后半年内就诊。153例中导管内癌22例（14.4%），浸润性癌131例（85.6%）。131例浸润性癌根据免疫组化分为腔面A型30例（22.9%），腔面B型65例（49.7%），Her-2过表达型18例（13.7%），基底样型18例（13.7%）。131例浸润性癌组织学分级以Ⅱ/Ⅲ级为主，分别为76例（58.0%）和32例（24.4%）；腔面A型初诊时直径≤2 cm和组织学分级Ⅰ级的肿瘤所占比例较其他型高；各型淋巴结转移数及临床分期均无统计学差异（P>0.05）。浸润性乳腺癌患者Ki67阳性率高，平均值为（30.12±3.91）%。结论 年轻女性乳腺癌患者初诊时分期较晚；肿瘤直径、组织学分级与乳腺癌分子分型密切相关；Ki67阳性率较高，且预后差的分子分型所占比例较高，提示年轻女性乳腺癌患者预后较差，应重视年轻女性乳腺癌的早期诊断。

关键词: 年轻女性, 分子分型, 临床特征, 乳腺肿瘤, 病理特征

Abstract: Objective To analyze the clinical and pathological features of breast cancer in women under 35 years of age. Methods 153 breast cancer patients aged 35 or younger treated from Jan. 1, 2007 to Dec. 31, 2012 were retrospectively reviewed. The characteristics of breast cancer onset and clinical and pathological features in different molecular subtypes of breast cancer were analyzed by SPSS 17.0 statistics software. Results The most common symptom among young patients was breast lumps, and 107 (69.9%) of the patients went to the hospital within six months as soon as the symptom was appeared. Among these 153 samples, 22 (14.4%) were diagnosed as having ductal carcinomas in situ, and 131 (85.6%) had invasive cancers. In addition, based on immunohistochemistry, the invasive cancers were categorized into four molecular subtypes: luminal A (30, 22.9%), luminal B (65, 49.7%), Her-2 over-expression (18, 13.7%) and basal-like (18, 13.7%). The most invasive cancers were in histological grades Ⅱ (76, 58.0%) and Ⅲ (2, 24.4%). In luminal A subtype, the diameter≤2 cm and histological grade Ⅰ ranked higher than in any other subtypes. There were no significant differences among different subtypes regarding lymph node metastasisand clinical stage. The invasive cancers had a high positive rate of Ki67, with an average of (30.12±3.91)%. Conclusion The clinical stages of young breast cancer patients are more advanced; tumor diameter and histological grade are closely related with molecular subtypes; the high positive rate of Ki67 and the high proportion of the molecular subtypes with adverse prognosis imply poor prognosis. We should pay more attention on the early diagnosis of young patients.

Key words: Breast tumor, Pathological features, Young women, Clinical features, Molecular subtypes

中图分类号: 

  • R737.9
[1] Abahssain H, Lalya I, El M F, et al. Breast cancer in moroccan young women: a retrospective study[J]. BMC Res Notes, 2010, 3(1):286-295.
[2] Parkin D M, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin, 2005, 55(2):74-108.
[3] Han W, Kim S W, Park I A, et al. Young age: an independent risk factor for disease-free survival in women with operable breast cancer[J]. BMC Cancer, 2004, 4:82-90.
[4] Nielsen T O, Hsu F D, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma[J]. Clin Cancer Res, 2004, 10(16):5367-5374.
[5] Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014[J]. CA Cancer J Clin, 2014, 64(1):9-29.
[6] 韦锦涛,黄文河,张国君.年轻乳腺癌的临床病理学特征与治疗策略[J].中华乳腺病杂志:电子版, 2013, 7(4):282-287.
[7] Han W, Kang S Y. Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer[J]. Breast Cancer Res Treat, 2010, 119(1):193-200.
[8] 汤红平,谢闺娥,黄犁,等. 106例青年女性乳腺癌临床病理特点的回顾性分析[J].中华乳腺病杂志:电子版, 2013, 7(3):184-187.
[9] 金琳芳,吴玉玉,冯静洁. 青年乳腺癌的临床病理特点分析[J].实用癌症杂志, 2012, 27(5):510-511.
[10] 张文婧,宋冰,谷川. 青年期女性乳腺癌的临床及病理特点[J].南方医科大学学报, 2010, 30(6):1458-1459.
[11] 赵菲,姜军,范林军,等. 青年女性乳腺癌35例临床分析[J].第三军医大学学报, 2003, 25(23):2086-2089.
[12] 王中华,徐兵河. 129例30岁以下女性乳腺癌的临床特点及预后分析[J].中华肿瘤杂志, 2005, 27(2):50-52.
[13] 邵志敏,沈镇宙,徐兵河.乳腺肿瘤学[M].上海:复旦大学出版社, 2013:616-620.
[14] Goldhirsch A, Wood W C, Coates A S, et al. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011[J]. Ann Oncol, 2011, 22(8):1736-1747.
[15] Prat A, Karginova O, Parker J S, et al. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes[J]. Breast Cancer Res Treat, 2013, 142(2):237-255.
[16] Gong P, Wang Y, Liu G, et al. New insight into Ki67 expression at the invasive front in breast cancer[J]. PLoS One, 2013, 8(1):e54912. doi:10.1371/journal.pone.0054912.Epub 2013 Jan 31.
[1] 李星凯,刘战业,姜运峰,李军. 原发性中央型和周围型肺鳞癌临床病理学及预后差异[J]. 山东大学学报（医学版）, 2017, 55(9): 73-78.
[2] 聂思月,王震,孙靖宇,刘杰,李娟,魏小娟,路春晓,吕兴龑,王淑云,孙玉萍. ANGPTL5在人胃癌组织中的表达及临床意义[J]. 山东大学学报（医学版）, 2017, 55(8): 61-65.
[3] 孟繁超,冯鹭,邵广瑞. 人乳腺癌细胞系MCF-7中FOXM1调控SYK转录[J]. 山东大学学报（医学版）, 2017, 55(3): 19-24.
[4] 田斯琦,刘日强,杨宁,韦薇,杨华伟. 核糖体S6蛋白激酶4变异体基因表达对乳腺癌细胞增殖的影响[J]. 山东大学学报（医学版）, 2016, 54(9): 32-36.
[5] 李冉冉,张鹏飞,袁冰,房菲菲, 韩明勇. 乳腺癌MCF-7细胞分泌的血管内皮生长因子诱导血管内皮细胞免疫功能抑制[J]. 山东大学学报（医学版）, 2016, 54(2): 38-43.
[6] 王光杰,俎树禄,张秀琳,徐祗顺,周春文,刘玉强,王绍勇. Von-Hippel-Lindau病并发肾癌2例[J]. 山东大学学报（医学版）, 2016, 54(2): 86-89.
[7] 刘永亮,王秀问. 老年直肠癌术后辅助化疗相关病理特征及预后多因素分析[J]. 山东大学学报（医学版）, 2016, 54(1): 48-51.
[8] 高永生, 王春健, 蔡淑萍, 孙菊杰, 张德贤, 孙妍琳, 穆殿斌. Netrin-1在乳腺浸润性导管癌中的表达及与转移的相关性[J]. 山东大学学报（医学版）, 2015, 53(7): 39-42.
[9] 姚冬雪, 赵琪, 秦成勇. miRNA-206在胃间质瘤组织中的表达及其临床意义[J]. 山东大学学报（医学版）, 2015, 53(12): 67-70.
[10] 张洪梅1,2，王宏2，陈洪丽2，李迎新2，徐应军1，关维俊1，顾立超3,陈乃耀3. PSD-007对人乳腺癌MCF-7细胞的光动力杀伤效应[J]. 山东大学学报（医学版）, 2014, 52(2): 52-57.
[11] 白杨1，崔国忠1，戴殿禄1，桑梅香2，耿翠芝3. Bax基因多态性与乳腺癌临床病理特点的关系[J]. 山东大学学报（医学版）, 2014, 52(1): 71-74.
[12] 石焕1,2，邵倩倩1，孙锦堂1，宋丙凤1，吕静1,3，何影1，张韵1，曲迅1. 罗勒多糖对乳腺癌细胞系MDA-MB-231侵袭的影响[J]. 山东大学学报(医学版), 2013, 51(9): 50-54.
[13] 迟蔚蔚1，高海燕2，高海东3. 转化生长因子β1诱导的跨膜蛋白参与乳腺癌发展的分子机制[J]. 山东大学学报(医学版), 2013, 51(4): 26-29.
[14] 李珊珊，孙颖，丁涣，黎莉. β-catenin在不同亚型乳腺癌中的表达及其临床意义[J]. 山东大学学报(医学版), 2013, 51(3): 107-110.
[15] 岑东芝. NRIP3基因高表达抑制淋巴结阴性乳腺癌转移的研究[J]. 山东大学学报(医学版), 2012, 50(9): 83-.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发